BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 90 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,608,000 | -28.2% | 73,936 | -30.2% | 0.33% | -37.6% |
| Q4 2018 | $6,417,000 | -4.0% | 105,892 | -7.3% | 0.53% | +47.4% |
| Q3 2018 | $6,681,000 | -8.0% | 114,230 | -29.4% | 0.36% | -9.5% |
| Q2 2018 | $7,260,000 | -0.8% | 161,839 | -2.0% | 0.40% | -6.8% |
| Q1 2018 | $7,320,000 | +0.1% | 165,085 | -2.2% | 0.43% | -0.5% |
| Q4 2017 | $7,310,000 | -7.6% | 168,714 | -0.8% | 0.43% | -13.7% |
| Q3 2017 | $7,913,000 | +9.9% | 170,102 | +17.0% | 0.50% | +6.9% |
| Q2 2017 | $7,199,000 | -13.0% | 145,406 | -3.7% | 0.47% | -7.9% |
| Q1 2017 | $8,278,000 | +1.8% | 151,063 | +3.4% | 0.51% | -7.8% |
| Q4 2016 | $8,135,000 | +29.0% | 146,052 | +5.7% | 0.55% | +32.3% |
| Q3 2016 | $6,308,000 | +20.4% | 138,129 | +5.3% | 0.42% | +11.3% |
| Q2 2016 | $5,238,000 | +24.6% | 131,147 | +8.7% | 0.37% | +19.9% |
| Q1 2016 | $4,203,000 | -4.8% | 120,693 | +17.5% | 0.31% | -1.0% |
| Q4 2015 | $4,414,000 | -4.8% | 102,718 | -3.6% | 0.31% | -16.3% |
| Q3 2015 | $4,638,000 | -4.3% | 106,520 | +13.5% | 0.38% | -13.8% |
| Q2 2015 | $4,844,000 | +48.5% | 93,879 | +12.6% | 0.44% | +28.3% |
| Q1 2015 | $3,263,000 | +31.9% | 83,357 | +30.2% | 0.34% | +6.6% |
| Q4 2014 | $2,473,000 | – | 64,022 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|